Medscape Medical NewsAll articles

Precise Image

Philips Medical Systems Nederland, B.V. • Radiology • 01/14/2022

510(k)IEC 62304 Class B
FDA Summary PDF

Device Purpose

Precise Image is an Artificial Intelligence-powered CT reconstruction software designed to reduce radiation dose while improving image quality, specifically enhancing low contrast detectability and reducing noise in adult CT imaging. Utilizing Convolutional Neural Networks, the software reconstructs X-ray transmission data to produce images with an appearance similar to traditional Filtered Back Projection, offering adjustable settings to optimize diagnostic outcomes for head, body, and vascular applications.

Summary

Precise Image is an advanced reconstruction software application designed for Philips whole-body Computed Tomography (CT) X-Ray Systems, utilizing Artificial Intelligence (AI) and Convolutional Neural Networks (CNN). Its primary purpose is to generate CT images that offer an image appearance similar to traditional Filtered Back Projection (FBP) images, while simultaneously reducing radiation dose and enhancing image quality. The software, which is trained on and compatible with the Philips Incisive CT System, aims to achieve lower noise levels and improve low contrast detectability. It provides five user-adjustable settings, allowing radiologists to tailor dose reduction and image quality according to their preferences for diagnostic imaging of the head, body, and vascular system in adult patients; it is not indicated for pediatric use. Compared to conventional methods like iDose, Precise Image is engineered for significantly lower radiation dose—claiming up to 80% dose reduction—while providing up to 85% lower noise and 60% better low contrast detectability, and an image appearance more akin to FBP at higher doses. Non-clinical testing showed improved low contrast resolution at lower dose levels (e.g., 5 mm @ 0.3% @ 5.5 mGy CTDIvol) and ensures the Noise Power Spectrum (NPS) does not shift by more than 6% when noise is reduced by at least 50%. Clinical performance was supported by a comparative image evaluation study where six board-certified radiologists assessed 55 image set pairs from Precise Image and predicate devices, evaluating diagnostic confidence, sharpness, noise, image texture, and artifacts, with all images deemed to have good image quality.

AI Regulatory Concerns

Powered byJev by TypeSafe AI

Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.

Keywords

Precise ImageComputed Tomography (CT)Image ReconstructionArtificial Intelligence (AI)Convolutional Neural Networks (CNN)Dose ReductionImage QualityLow Contrast DetectabilityNoise ReductionFiltered Back Projection (FBP)

Device Metadata

Submission Number
K210760
Company
Philips Medical Systems Nederland, B.V.
Panel
Radiology
Product Code
N/A
Data Type
Images
Clinical Function
Assessment
AI Function
Generation
AI Subclass
image enhancement

Relevant Clinical Questions

  • Q1. How does the Precise Image AI algorithm specifically balance the trade-off between noise reduction, low contrast detectability, and image texture to mimic Filtered Back Projection images across different anatomical regions and patient sizes, particularly at significantly lower doses?; What were the specific quantitative results from the comparative image evaluation study (e.g., mean Likert scores for diagnostic confidence, sharpness, noise) when comparing Precise Image to the predicate Incisive CT, especially at the claimed 80% lower dose?; The document states Precise Image has 5 user-adjustable settings. What are these settings, how do they interact, and what training is recommended for radiologists to optimize image quality and dose reduction for specific clinical scenarios?; Given the training on the Philips Incisive CT system, how robust is the Precise Image algorithm to variations in data from different CT scanners within the Philips family, or to variations in acquisition protocols not included in the initial training dataset?; What are the computational performance implications, such as reconstruction time, of using the Precise Image AI algorithm compared to standard FBP or iterative reconstruction methods like iDose on the Philips Incisive CT system?

Risk Classification

ESL Analysis
FDA Device ClassII

FDA Class II via 510(k) pathway; IEC 62304 Class B (software safety classification); Authorized before §524B enforcement

Learn how Parasoft automates IEC 62304 compliance testing →

Cybersecurity Evidence

Powered by SBOMator™

Based on AI-generated device summaries, not the full FDA submission. Items not detected here may still be present in the complete submission package.

Cyber Score10/100
SBOM Evidence⚠ Not mentioned in summary
Cyber Risk Assessment⚠ Not mentioned in summary
Postmarket Plan⚠ Not mentioned in summary
§524B ApplicableNo

Supply Chain BOM Evidence

Based on the CycloneDX / OWASP ECMA-424 xBOM ecosystem. Detection is from the AI-generated summary.

SBOMSoftware Bill of Materials
- Not detected
ML-BOMMachine Learning Bill of Materials(training data, neural network, algorithm, dataset)
✓ Detected
SaaSBOMSoftware-as-a-Service Bill of Materials(network)
✓ Detected
HBOMHardware Bill of Materials
- Not detected
CBOMCryptography Bill of Materials
- Not detected
VDR/VEXVulnerability Disclosure Report / Vulnerability Exploitability eXchange
- Not detected
OBOMOperations Bill of Materials
- Not detected

Analysis:

• Analysis is based on the AI-generated device summary, not the full FDA submission package. Click "Analyze Full FDA PDF" below to scan the actual submission document.

• Evidence of ML-BOM, SaaSBOM detected in AI-generated device summary.

• This device was authorized before §524B took effect. Cybersecurity evidence requirements were less prescriptive at the time.

• Postmarket cybersecurity monitoring plan not clearly documented in AI-generated device summary.

• Not detected in AI-generated device summary: SBOM, HBOM, CBOM, VDR/VEX, OBOM. These may be present in the full FDA submission.

Preparing a similar submission?

ESL takes complete ownership of your software evidence work - SBOM & CVE remediation with SBOMator™, static analysis & unit testing with Parasoft, traceability, and full IEC 62304 lifecycle support.

Assess Your Readiness →Or contact ESL directly
Precise Image - Philips Medical Systems Nederland, B.V. | ESL FDA AI Device Intelligence